Similar articles

• Synthesis and antiarrhythmic activity of new [(dialkylamino)alkyl]pyridylacetamides.

  Bernhart CA, Condamine C, Demarne H, Roncucci R, Gagnol JP, Gautier PJ, Serre MA. Bernhart CA, et al. J Med Chem. 1983 Mar;26(3):451-5. doi: 10.1021/jm00357a026. J Med Chem. 1983. PMID: 6827566 No abstract available.
• Quantum statistical calculation for the correlation of biological activity and chemical structure. 3. Diisopyramide phosphate and related compounds as antiarrhythmic agents.

  Lin TK, Chien YW, Dean RR, Dutt JE, Sause HW, Yen CH, Yonan PK. Lin TK, et al. J Med Chem. 1974 Jul;17(7):751-3. doi: 10.1021/jm00253a021. J Med Chem. 1974. PMID: 4836408 No abstract available.
• Linear relationships between plasma binding and lipophilicity of disopyramide derivatives.

  Chien YW, Lambert HJ, Lin TK. Chien YW, et al. J Pharm Sci. 1975 Jun;64(6):961-6. doi: 10.1002/jps.2600640614. J Pharm Sci. 1975. PMID: 1133751
• Compounds related to 4-disopropylamino-2-phenyl-2(2-pyridyl)butyramide. Their synthesis and antiarrhythmic activity.

  Yen CH, Lowrie HS, Dean RR. Yen CH, et al. J Med Chem. 1974 Nov;17(11):1131-5. doi: 10.1021/jm00257a001. J Med Chem. 1974. PMID: 4412561 No abstract available.
• A review of the effects of disopyramide phosphate on left ventricular function and the peripheral circulation.

  Di Bianco R, Gottdiener JS, Singh SN, Fletcher RD. Di Bianco R, et al. Angiology. 1987 Feb;38(2 Pt 2):174-83. Angiology. 1987. PMID: 3103491 Review.